Danaher (DHR)
(Delayed Data from NYSE)
$252.14 USD
+5.91 (2.40%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $252.23 +0.09 (0.04%) 5:52 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Brokerage Reports
Danaher Corporation [DHR]
Reports for Purchase
Showing records 221 - 240 ( 503 total )
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
With or Without COVID-19 - a Long Tail of Growth into 2021 and 2022
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
D.C. Very Friendly with Biden "American Rescue Plan";
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
4Q Pre-Announcement - Global Vaccine Production Underway
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Bioproduction: FDA Advisory Committee COVID-19 Vaccine Hearing Highlights
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Life Science Tools: ''De-Icing'' the COVID-19 Vaccine with Timeline, Production Pictures, Tool Opportunity
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Comprehensive Technical and Fundamental Analysis for DHR.
Provider: Stock Traders Daily
Analyst: Research Department